



Writing business grows from medical profession Cincinnati.com Geis helped develop and obtain approval for the popular arthritis medication, Celebrex, in 1998. He says that effort required more than 50 clinical trials and 56 major documents with thousands of pages of material – enough to fill a tractor trailer ... |
Posted on 20 May 2012 | 4:18 am
For the Treatment of Osteoarthritic Pain, Clinical Data and Interviewed ... EON: Enhanced Online News (press release) Clinical data and the opinions of interviewed thought leaders indicate that Pfizer's tanezumab has advantages on this attribute over Pfizer's Celebrex, the sales-leading agent for osteoarthritic pain. The DecisionBase 2012 report entitled ... |
Posted on 16 May 2012 | 9:00 am
Decreased Risk for Upper, Lower GI Events With COX-2 Inhibitor Compared With ... Pain Medicine News by Ted Bosworth National Harbor, Md.—A large randomized, “real-world” study demonstrated that celecoxib (Celebrex, Pfizer) is associated with a lower risk for upper and lower gastrointestinal (GI) events compared with nonselective nonsteroidal ... |
Posted on 16 May 2012 | 5:43 am
For the Treatment of Osteoarthritic Pain, Clinical Data and Interviewed ... MarketWatch (press release) Clinical data and the opinions of interviewed thought leaders indicate that Pfizer's tanezumab has advantages on this attribute over Pfizer's Celebrex, the sales-leading agent for osteoarthritic pain. The DecisionBase 2012 report entitled ... |
Posted on 15 May 2012 | 3:01 pm
Religion news in brief Fox News ____ Pfizer settles BYU lawsuit for $450 million, suit over credit for developing painkiller Celebrex SALT LAKE CITY (AP) — Pfizer Inc. has settled a lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex for ... |
Posted on 3 May 2012 | 12:11 am
![]() Science Codex | Scientists Spot How Cox-2 Painkillers Raise Heart Risks U.S. News & World Report Meanwhile, Celebrex, a painkiller in the same drug class that remains on the market, carries a "black box" warning alerting patients to potential heart risks. Now, a team of scientists from the University of Pennsylvania in Philadelphia say that, ... WSJ BLOG/Health: Studies Shine Light on How Vioxx Raises Heart Risks |
Posted on 2 May 2012 | 10:05 pm
Pfizer settles lawsuit involving Celebrex Atlanta Journal Constitution By PAUL FOY AP SALT LAKE CITY — Pfizer Inc. has settled a lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex for $450 million, according to a regulatory filing Tuesday. Terms of the settlement weren't ... |
Posted on 2 May 2012 | 1:58 pm
![]() NEWS.com.au | Charges, generic Lipitor cut Pfizer Q1 net 19 pct BusinessWeek According to a Pfizer regulatory filing, the suit concerned predecessor companies that Pfizer bought allegedly breaching a 1991 agreement on research involved in the discovery of blockbuster painkiller Celebrex. Revenue totaled $15.4 billion, ... Pfizer Q1 profit falls 19 pct on generic Lipitor Pfizer Reports First-Quarter 2012 Results Charges, generic Lipitor cut Pfizer 1Q net 19 pct |
Posted on 2 May 2012 | 6:48 am
![]() USA TODAY | Pfizer settles lawsuit involving Celebrex USA TODAY By Paul Foy, AP SALT LAKE CITY – Pfizer Inc. has settled a lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex for $450 million, according to a regulatory filing Tuesday. Pfizer Inc.'s painkiller Bextra is ... Pfizer settles school's lawsuit involving development of painkiller Celebrex ... Filings: Pfizer settles lawsuit involving Celebrex Pfizer Settles Suit Involving Celebrex |
Posted on 1 May 2012 | 10:32 pm
Pfizer says BYU tainted Utah jury pool for trial Salt Lake Tribune The New York-based drug company is asking US District Judge Ted Stewart to move the trial to either New York or Missouri, where Monsanto first engaged Simmons about his discoveries and started development of what became Celebrex. |
Posted on 27 April 2012 | 11:52 pm